All lobbying filings

VENTURE GOVERNMENT STRATEGIES, LLC (FKA HOBART HALLAWAY & QUAYLE VENTURES, LLC)

Lobbying for CLINICAL REFERENCE LABORATORY, INC. · privately held clinical testing laboratory

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 18, 2026

Income

$20,000.00

What the client paid this registrant for the period.

Client based in

Kansas

Official filing document

Government bodies contacted 3

HOUSE OF REPRESENTATIVES
SENATE
Transportation, Dept of (DOT)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

HR 4320
Drug and Alcohol Clearinghouse Public Safety Improvement Act of 2025

Lobbying activity 1

Medical/Disease Research/Clinical Labs

Policies and regulations impacting clinical laboratories and drug testing, including issues related to HHS and DOT; H.R.4320, Drug and Alcohol Clearinghouse Public Safety Improvement Act of 2025; DOT Rule 49 CFR Part 40 Section 40.82.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.